The analgesic effect of remifentanil on prevention of withdrawal response associated with the injection of rocuronium in children

No evidence for a peripheral action

J. R. Yoon, Y. Jeon, Young Yoo, H. J. Shin, J. H. Ahn, Choon Hak Lim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Remifentanil pre-treatment has been reported to decrease the incidence of rocuronium injection-associated withdrawal movement. This study was designed to explore the site of action of remifentanil for reducing withdrawal response during rocuronium injection in children. Ninety-six paediatric patients were randomly assigned to three groups. After induction of anaesthesia with 5 mg/kg 2.5% thiopental sodium, 2 ml saline (placebo group) or 0.5 μg/kg remifentanil (group R), was injected intravenously 1 min before 0.6 mg/kg rocuronium. In a third group(group R′), the venous retention of 0.5 μg/kg remifentanil was maintained for 30 s followed by tourniquet release and injection of 0.6 mg/kg rocuronium. Withdrawal response was graded using a four-point scale. The incidence of withdrawal movement after rocuronium administration was 94%, 22% and 81% in the placebo, R, and R′ groups, respectively. This study demonstrated that the pre-treatment effect of remifentanil for reducing rocuronium-associated withdrawal response occurs mainly through a central action.

Original languageEnglish
Pages (from-to)1795-1800
Number of pages6
JournalJournal of International Medical Research
Volume38
Issue number5
DOIs
Publication statusPublished - 2010 Jan 1

Fingerprint

Analgesics
Injections
Placebos
Tourniquets
Pediatrics
Thiopental
Incidence
remifentanil
rocuronium
Anesthesia
Therapeutics

Keywords

  • Children
  • Pain
  • Remifentanil
  • Rocuronium
  • Withdrawal response

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biochemistry, medical

Cite this

@article{304490eea8a34d28bfde87b00f71a62e,
title = "The analgesic effect of remifentanil on prevention of withdrawal response associated with the injection of rocuronium in children: No evidence for a peripheral action",
abstract = "Remifentanil pre-treatment has been reported to decrease the incidence of rocuronium injection-associated withdrawal movement. This study was designed to explore the site of action of remifentanil for reducing withdrawal response during rocuronium injection in children. Ninety-six paediatric patients were randomly assigned to three groups. After induction of anaesthesia with 5 mg/kg 2.5{\%} thiopental sodium, 2 ml saline (placebo group) or 0.5 μg/kg remifentanil (group R), was injected intravenously 1 min before 0.6 mg/kg rocuronium. In a third group(group R′), the venous retention of 0.5 μg/kg remifentanil was maintained for 30 s followed by tourniquet release and injection of 0.6 mg/kg rocuronium. Withdrawal response was graded using a four-point scale. The incidence of withdrawal movement after rocuronium administration was 94{\%}, 22{\%} and 81{\%} in the placebo, R, and R′ groups, respectively. This study demonstrated that the pre-treatment effect of remifentanil for reducing rocuronium-associated withdrawal response occurs mainly through a central action.",
keywords = "Children, Pain, Remifentanil, Rocuronium, Withdrawal response",
author = "Yoon, {J. R.} and Y. Jeon and Young Yoo and Shin, {H. J.} and Ahn, {J. H.} and Lim, {Choon Hak}",
year = "2010",
month = "1",
day = "1",
doi = "10.1177/147323001003800526",
language = "English",
volume = "38",
pages = "1795--1800",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "5",

}

TY - JOUR

T1 - The analgesic effect of remifentanil on prevention of withdrawal response associated with the injection of rocuronium in children

T2 - No evidence for a peripheral action

AU - Yoon, J. R.

AU - Jeon, Y.

AU - Yoo, Young

AU - Shin, H. J.

AU - Ahn, J. H.

AU - Lim, Choon Hak

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Remifentanil pre-treatment has been reported to decrease the incidence of rocuronium injection-associated withdrawal movement. This study was designed to explore the site of action of remifentanil for reducing withdrawal response during rocuronium injection in children. Ninety-six paediatric patients were randomly assigned to three groups. After induction of anaesthesia with 5 mg/kg 2.5% thiopental sodium, 2 ml saline (placebo group) or 0.5 μg/kg remifentanil (group R), was injected intravenously 1 min before 0.6 mg/kg rocuronium. In a third group(group R′), the venous retention of 0.5 μg/kg remifentanil was maintained for 30 s followed by tourniquet release and injection of 0.6 mg/kg rocuronium. Withdrawal response was graded using a four-point scale. The incidence of withdrawal movement after rocuronium administration was 94%, 22% and 81% in the placebo, R, and R′ groups, respectively. This study demonstrated that the pre-treatment effect of remifentanil for reducing rocuronium-associated withdrawal response occurs mainly through a central action.

AB - Remifentanil pre-treatment has been reported to decrease the incidence of rocuronium injection-associated withdrawal movement. This study was designed to explore the site of action of remifentanil for reducing withdrawal response during rocuronium injection in children. Ninety-six paediatric patients were randomly assigned to three groups. After induction of anaesthesia with 5 mg/kg 2.5% thiopental sodium, 2 ml saline (placebo group) or 0.5 μg/kg remifentanil (group R), was injected intravenously 1 min before 0.6 mg/kg rocuronium. In a third group(group R′), the venous retention of 0.5 μg/kg remifentanil was maintained for 30 s followed by tourniquet release and injection of 0.6 mg/kg rocuronium. Withdrawal response was graded using a four-point scale. The incidence of withdrawal movement after rocuronium administration was 94%, 22% and 81% in the placebo, R, and R′ groups, respectively. This study demonstrated that the pre-treatment effect of remifentanil for reducing rocuronium-associated withdrawal response occurs mainly through a central action.

KW - Children

KW - Pain

KW - Remifentanil

KW - Rocuronium

KW - Withdrawal response

UR - http://www.scopus.com/inward/record.url?scp=78449302704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78449302704&partnerID=8YFLogxK

U2 - 10.1177/147323001003800526

DO - 10.1177/147323001003800526

M3 - Article

VL - 38

SP - 1795

EP - 1800

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 5

ER -